6. Supporting Ukrainian Cancer Patients and Cancer Services: Immediate Needs and Longer-term Rebuilding
European Cancer Organisation
177 videos
Welcome! From here you can access useful information and resources from the European Cancer Organisation, its European Cancer Summit 2022, Member Societies, Patient Advocacy Groups and Community...
Read More
Welcome! From here you can access useful information and resources from the European Cancer Organisation, its European Cancer Summit 2022, Member Societies, Patient Advocacy Groups and Community 365.
European Cancer Organisation
Speakers
Dr Hans Henri P. Kluge is the WHO Regional Director for Europe. His term began on 1 February 2020, following his...
Dr Hans Henri P. Kluge is the WHO Regional Director for Europe. His term began on 1 February 2020, following his nomination by the WHO Regional Committee for Europe and appointment by the WHO Executive Board. Throughout his career, beginning as a family doctor in Belgium, along a journey to Somalia, Liberia, the prisons in Siberia, former Soviet Union countries, Myanmar and the Democratic People’s Republic of Korea, and most recently leading the Division of Health Systems and Public Health at WHO/Europe for a decade, Dr Kluge has always been committed to achieving better health for all with a focus on the vulnerable. As Regional Director, Dr Kluge’s vision for the WHO European Region is “United action for better health”, working in partnership to achieve universal health coverage, address health emergencies and promote healthier populations. Dr Kluge is from Belgium. He is married and has two daughters.
Richard Sullivan is Editor-in-chief, Journal of Cancer Policy Director, Institute of Cancer Policy, King's College...
Richard Sullivan is Editor-in-chief, Journal of Cancer Policy Director, Institute of Cancer Policy, King's College London & Professor of Cancer and Global Health at King’s College London, and Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group (kcl.ac.uk/research/conflict-health-research-group). His research interests extend from global cancer to conflict & health. Richard has worked on a number of Lancet and Lancet Oncology commissions, currently the Lancet Commission on Global Diagnostics (diagnosticscommission.org) and the Lancet Oncology European Cancer Research Commission. Richard’s research teams have major programs in capacity building in conflict and health, and humanitarian medicine, particularly in the Middle East and North Africa (r4hc-mena.org), as well as programmes in women’s health and cancer, digital innovation (virtual-reality enhanced surgery) and a wide range of global health security projects including on the COVID-19 pandemic and strengthening health systems in NW and NE Syria. His global cancer research programs cover cancer systems strengthening, affordability, value particularly and political economy, global radiotherapy, social welfare and cancer care in conflict. Professor Sullivan qualified in medicine and trained in surgery (urology) gaining his PhD in Biochemistry from University College London. Richard was Clinical Director of Cancer Research UK between 1999 and 2008. He has also worked for many years on biosecurity and counterproliferation issues, including Ebola outbreaks in West Africa and DR Congo. Richard is an NCD advisor to the WHO, a member of the National Cancer Grid of India and advisor (civil-military) to Save the Children.
Start a conversation